Not a healthcare professional? Visit our Public site
Not a healthcare professional? Visit our Public site
Registration successful
You now have access to the latest updates, events and resources.
Registration successful
You now have successfully registered for the event and for an account on this website.
In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Registration completed – pending validation
Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result of the validation process. Please note this could take up to 10 days.
In the meantime, you can continue to access all the unlocked content on this website.
Account activated - pending validation.
Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can continue to access the unlocked content of the website.
Registration completed - pending validation.
Your account has been activated successfully, but we still need to validate you as a Healthcare Professional registered in Ireland. We’ll send you an email with the result of the validation process. Please note this could take up 10 days.
In the meantime, you can continue to access all the unlocked content on this website.
In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.
Asthma is like an iceberg. Symptoms like breathlessness, coughing and a tight chest, as well as exacerbations, only represent the visible part of the problem.1,2
Although the symptoms that they can see and feel may be of most importance to your patients, the invisible symptoms that lie beneath the surface, such as bronchial hyperresponsiveness, chronic inflammation and airway remodelling, may be present.2
MART regimens rely on patient perceptions to control symptoms, but these are unreliable3 and do not address underlying inflammation. See how switching to Relvar can benefit patients controlled on a MART regimen.
Daytime asthma symptoms more than twice/week?
Any night waking due to asthma?
SABA reliever for symptoms more than twice/week?
Any activity Limitation due to asthma?
Each question requires a ‘yes’ or ‘no’ answer, scored as 1 or 0 respectively.
The composite score from this assessment then determines the patient’s level of asthma control:
For patients, the clinically-validated Asthma Control Test (ACT) is a useful way for them to better understand and improve their perception of asthma control.
The test is based on the four GINA indicators above, but also includes the patient’s perception of asthma control:
All assessment questions refer to the previous 4 weeks and are answered with a score of 1 to 5.4,5
The composite score indicates the level of asthma control:
An improvement of 3 points is the minimal clinically important difference.4
The GINA guidelines define well controlled as no symptoms.1
Visit the ACT website, here.
Abbreviations
ACT, Asthma Control Test; GINA, Global Initiative for Asthma; MART, maintenance and reliever therapy.
RELVAR Ellipta was created in collaboration with
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Relvar is a registered trademark of the GlaxoSmithKline group of companies
PM-IE-FFV-WCNT-230006 January 2024
Please update your operating system or use a different device.
